Zacks Investment Research on MSN
Halozyme's Q4 earnings miss, higher royalties drive Y/Y revenues
Halozyme Therapeutics HALO reported fourth-quarter 2025 adjusted loss of 24 cents per share against the Zacks Consensus Estimate of earnings of $2.15. The company had reported adjusted earnings of $1.
Zacks Investment Research on MSN
Here's how much a $1000 investment in Halozyme Therapeutics made 10 years ago would be worth today
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...
Palou's ad, titled "Indy Speed," shows the four-time IndyCar champ checking out milk at a grocery store. The commercial ends with a montage of Palou winning last year's Indy 500 and drinking milk at ...
The surprise trailer for The Adventures of Cliff Booth at the Super Bowl was the only teaser to effectively build hype for ...
Dunkin’ and Ben Affleck have done it again, this time with a spoof of one of the actor’s most famous films, “Good Will ...
ANAHEIM -- With exactly a week before Angels pitchers and catchers hold their first Spring Training workouts, the club announced its list of non-roster invitees to camp on Wednesday, highlighted by ...
From the emotionally manipulative to the occasionally clever, the champions of USA TODAY's Ad Meter competition have pulled almost every lever available. This year figures to be no exception. A look ...
SCHENECTADY, N.Y. (WNYT)- Chilling new photos show the dark, cold hole where a baby spent the last minutes of her life. It’s murder trial evidence never before made public. Related: Mom found guilty ...
SHANGHAI, CHINA, January 20, 2026 /EINPresswire.com/ — QingLing ISUZU Motors Import & Export Co., Ltd., a leading commercial and specialty trucks manufacturer based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results